David J Bearss Selected Research

David J Bearss Research Topics

Disease

21	Neoplasms (Cancer) 01/2021 - 04/2002
6	Pancreatic Neoplasms (Pancreatic Cancer) 11/2011 - 05/2002
3	Disease Progression 01/2019 - 05/2014
3	Carcinoma (Carcinomatosis) 11/2015 - 09/2004
3	Colorectal Neoplasms (Colorectal Cancer) 12/2013 - 01/2003
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2021 - 12/2018
2	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2013
2	Multiple Myeloma 05/2014 - 01/2014
2	Neoplasm Metastasis (Metastasis) 12/2011 - 02/2011
2	Carcinogenesis 09/2004 - 03/2003
1	Prostatic Neoplasms (Prostate Cancer) 01/2019
1	Urinary Bladder Neoplasms (Bladder Cancer) 05/2014
1	Head and Neck Neoplasms (Head and Neck Cancer) 05/2014
1	Leukemia 05/2014
1	Lymphoma (Lymphomas) 05/2014
1	Infections 12/2013
1	Inflammatory Breast Neoplasms 11/2013
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2013
1	Polycythemia Vera 01/2011
1	Primary Myelofibrosis (Myelosclerosis) 01/2011
1	Hypersensitivity (Allergy) 09/2002
1	Breast Neoplasms (Breast Cancer) 06/2002

Drug/Important Bio-Agent (IBA)

8	Phosphotransferases (Kinase)IBA 01/2021 - 01/2003
5	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 05/2014 - 01/2003
4	Proteins (Proteins, Gene)FDA Link 09/2004 - 04/2002
2	proto-oncogene proteins pimIBA 11/2015 - 05/2014
2	Biomarkers (Surrogate Marker)IBA 05/2014 - 01/2013
2	Aurora Kinase AIBA 11/2011 - 10/2008
2	Cytotoxins (Cytolysins)IBA 10/2011 - 08/2002
2	Messenger RNA (mRNA)IBA 05/2004 - 05/2002
2	Aurora KinasesIBA 03/2003 - 01/2003
1	CateninsIBA 01/2021
1	UbiquitinIBA 01/2021
1	Janus Kinase InhibitorsIBA 01/2020
1	dubermatinibIBA 01/2020
1	ruxolitinibIBA 01/2020
1	Proto-Oncogene Proteins c-etsIBA 01/2019
1	ibrutinibIBA 12/2018
1	Axl Receptor Tyrosine KinaseIBA 12/2018
1	IsoenzymesIBA 06/2014
1	Pyruvate KinaseIBA 06/2014
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2014
1	Bortezomib (Velcade)FDA Link 01/2014
1	Oxidoreductases (Dehydrogenase)IBA 12/2013
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2013
1	Histones (Histone)IBA 12/2013
1	Lysine (L-Lysine)FDA Link 12/2013
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2011
1	LigandsIBA 10/2011
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2011
1	SGI-1252IBA 01/2011
1	Janus Kinase 2IBA 01/2011
1	KalininIBA 09/2004
1	Extracellular Matrix ProteinsIBA 09/2004
1	Integrin alpha6beta4IBA 09/2004
1	Antisense OligonucleotidesIBA 05/2004
1	Polo-Like Kinase 1IBA 05/2004
1	NucleotidesIBA 04/2004
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2003
1	PlatinumIBA 02/2003
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2003
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2003
1	Cisplatin (Platino)FDA LinkGeneric 02/2003
1	ElementsIBA 09/2002
1	Telomerase (Telomerase Reverse Transcriptase)IBA 06/2002
1	PorphyrinsIBA 06/2002
1	AntigensIBA 06/2002
1	tetra(4-N-methylpyridyl)porphineIBA 06/2002
1	VaccinesIBA 06/2002
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 06/2002
1	ParaffinIBA 05/2002
1	Complementary DNA (cDNA)IBA 05/2002
1	CyclinsIBA 04/2002
1	Cyclin D1IBA 04/2002

Therapy/Procedure

4	Therapeutics 12/2018 - 01/2013